Investors will watch for management commentary on the US recovery outlook, particularly around the uptake of Lanreotide and ...

An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom ...

New research into antimicrobial peptides, small chains of amino acids able to damage bacterial cells, shows why some peptides are more effective at doing that and also why some cells are more ...

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. In a shocking display of political ...

Somewhere around 2009, there was an argument brewing at UFC headquarters. The team in the main Las Vegas office was working up a profile on this new Dutch kid the promotion had just signed when ...

From “Wolverine Stacks” to “Vitality Protocols,” biohackers claim these peptide cocktails can heal injuries, boost energy, and reverse aging. Experts warn it may be riskier than it seems. Some ...

Peptide stacking is making waves in the fitness community—and for good reason. If you’re looking to rebuild lost muscle, stacking peptides may be a beneficial addition to your wellness routine. We ...

Ludrick Cooper, an eighth-grade teacher in South Carolina, didn’t always like the idea of using artificial intelligence – in the classroom or otherwise. But he eventually came around. “This is the new ...

Tomato plants possess a sophisticated system to protect themselves against herbivores: the signaling peptide Systemin triggers a cascade of plant defense responses. A research team from the University ...

What won’t we try to feel, perform, and look younger? While some aging-obsessed people transfuse the blood of their teenage offspring into their own, others are running away from canola oil as fast as ...

One of those Baker lab spin-offs is Vilya, which uses computational protein design to create membrane- permeable macrocyclic drugs. When the biotech venture capital firm Arch Venture Partners met the ...